Drugs that contain Ipratropium Bromide
1. Atrovent Hfa patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5676930 | BOEHRINGER INGELHEIM | Stabilized medicinal aerosol solution formulations |
Oct, 2014
(9 years ago) | |
| US5683677 | BOEHRINGER INGELHEIM | Medicinal aerosol formulations |
Nov, 2014
(9 years ago) | |
| US6739333 | BOEHRINGER INGELHEIM | Stainless steel canister for propellant-driven metering aerosols |
May, 2020
(3 years ago) | |
| US6983743 | BOEHRINGER INGELHEIM | Stainless steel canister for propellant-driven metering aerosols |
May, 2020
(3 years ago) | |
| US8474447 | BOEHRINGER INGELHEIM | Inhaler device |
Jan, 2030
(5 years from now) | |
Market Authorisation Date: 27 November, 2004
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
More Information on Dosage
ATROVENT HFA family patents
